FTC Names Pay-For-Delay Czar To Interim Antitrust Post

Law360, Los Angeles (November 3, 2015, 10:52 PM EST) -- A Federal Trade Commission veteran responsible for heading up the antitrust watchdog’s efforts to thwart so-called pay-for-delay settlements paid by brand-name drugmakers was tapped as acting deputy director of the FTC’s Bureau of Competition on Tuesday, following the recent departure of Stephen Weissman for Baker Botts LLP.

Markus H. Meier, assistant director of the health care division, steps in for Weissman, who said on Oct. 28 he would be leaving to rejoin Baker Botts as co-chair of its antitrust practice after serving a two-year tenure overseeing the FTC’s mergers, health care and conduct units.

In naming Meier acting deputy, Deborah L....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS